Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France

21st January 2020 Uncategorised 0

As Brexit draws near, British pharma major AstraZeneca is investing more in continental Europe, just as it cuts back in its home country. The company unveiled a $520 million investment in France across the spectrum of manufacturing and R&D over five years, promising to add about 150 jobs along the way.

More: Amid U.K. cutbacks, AstraZeneca plows 0M into manufacturing and R&D in France
Source: fierce